Plunkett Research Online: Cipher Pharmaceuticals Inc.

CIPHER PHARMACEUTICALS INC. (CPH:TSE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cipher Pharmaceuticals Inc. is a drug development company focused on the commercialization of the novel formulations of currently marketed molecules using advanced drug delivery technologies......



Cipher Pharmaceuticals Inc.
Ticker: CPH
Exchange: TSE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 905 696-9380
Fax: 905 602-0628
Address: 2345 Argentia Road
Suite 100A
Mississauga, ON L5N 8K4 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Norman EvansCFO/Secretary
Gerald McdoleChairman of the Board/Director
See More
Cipher Pharmaceuticals Inc. is a drug development company focused on the commercialization of the novel formulations of currently marketed molecules using advanced drug delivery technologies......See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: